Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.
暂无分享,去创建一个
F Locatelli | C Chastang | C. Chastang | F. Locatelli | F. Locatelli | E. Gluckman | V. Rocha | J. Jouet | W. Arcese | E. Plouvier | C. Messina | G. Michel | G. Souillet | W Arcese | R. Pasquini | J. Ortega | V Rocha | E Gluckman | G Souillet | G Michel | M Abecasis | C Messina | J Ortega | I Badell-Serra | E Plouvier | J P Jouet | R Pasquini | E Ferreira | F Garnier | I. Badell-Serra | F. Garnier | M. Abecasis | C. Chastang | E. Ferreira | Isabel Badell-Serra | Emanuel Plouvier | E. Plouvier
[1] J. Adamson,et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.
[2] Anajane G. Smith,et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.
[3] Takato O. Yoshida,et al. EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .
[4] G. Janossy,et al. Intracellular cytokine profile of cord and adult blood lymphocytes. , 1998, Blood.
[5] D. Reen,et al. Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. , 1998, Blood.
[6] D. Srivastava,et al. Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia , 1997, The Lancet.
[7] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors , 1997 .
[8] R Storb,et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. , 1997, Blood.
[9] J. Wagner,et al. Unrelated donor bone marrow transplantation for children with acute leukemia. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] G. Gerna,et al. High frequency of Epstein–Barr virus (EBV) lymphoblastoid cell line‐reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL‐2 production , 1997, Clinical and experimental immunology.
[11] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.
[12] G. Hale,et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission , 1996, British journal of haematology.
[13] J. Wagner,et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. , 1996, Blood.
[14] J. Kurtzberg,et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.
[15] A. Barrett,et al. GRAFT‐VERSUS‐LEUKAEMIA: UNDERSTANDING AND USING THE ALLOIMMUNE RESPONSE TO TREAT HAEMATOLOGICAL MALIGNANCIES , 1996, British journal of haematology.
[16] J. Adamson,et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[17] K. Sullivan,et al. Unrelated donor marrow transplantation in children. , 1995, Blood.
[18] A Ferrant,et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.
[19] S. Mackinnon,et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. , 1995, Blood.
[20] J. Wagner,et al. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease , 1995, The Lancet.
[21] N. Flomenberg,et al. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. , 1995, Bone marrow transplantation.
[22] C. Herwartz,et al. Leukemia-specific allogeneic donor T cells: quantification by limiting dilution assay. , 1995, Bone marrow transplantation.
[23] J. Shuster,et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. , 1994, The New England journal of medicine.
[24] D. Harris,et al. Analysis of the alloreactive capacity of human umbilical cord blood: implications for graft-versus-host disease. , 1994, Bone marrow transplantation.
[25] J. Hansen,et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.
[26] D. Deluca,et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Falkenburg,et al. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia , 1992, The Journal of experimental medicine.
[28] R. Tattersall,et al. Are diabetic pre-pregnancy clinics worth while? , 1992, The Lancet.
[29] S. Richards,et al. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALLX , 1992, The Lancet.
[30] S. Richards,et al. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X. , 1992, Lancet.
[31] H. Bolouri,et al. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. , 1992, Annals of hematology.
[32] A. B. Kay,et al. Lymphocytes , 1991 .
[33] R Hartmann,et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. , 1991, Blood.
[34] A. Rimm,et al. Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.
[35] J. Sosman,et al. Specific recognition of human leukemic cells by allogeneic T cell lines. , 1989, Transplantation.
[36] G. Santos. Marrow transplantation in acute nonlymphocytic leukemia. , 1989, Blood.
[37] James,et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. , 1989, Blood.
[38] R. Maccario,et al. T and NK Lymphocyte Subpopulations in the Neonate , 1987 .
[39] H. Kolb. Allogeneic bone marrow transplantation in leukemia. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[40] R. Nuscher,et al. Bone marrow transplantation. , 1977, The American journal of nursing.
[41] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.
[42] R. Storb,et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. , 1979, The New England journal of medicine.
[43] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.